LSE - Delayed Quote GBp
Poolbeg Pharma PLC (POLB.L)
2.9025
-0.1225
(-4.05%)
As of 10:20:54 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-4.38M
-4.38M
-4.37M
-2.15M
Investing Cash Flow
359.00k
359.00k
-388.00k
-81.00k
Financing Cash Flow
0.00
0.00
0.00
23.18M
End Cash Position
12.17M
12.17M
16.19M
20.95M
Capital Expenditure
-175.00k
-175.00k
-597.00k
-81.00k
Issuance of Capital Stock
--
--
0.00
23.18M
Issuance of Debt
--
--
0.00
225.00k
Repayment of Debt
--
--
0.00
-225.00k
Free Cash Flow
-4.56M
-4.56M
-4.96M
-2.23M
12/31/2021 - 7/19/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HVO.L hVIVO plc
17.86
-2.93%
25I.F ImmuPharma plc
0.0300
+46.34%
CIZ.L Cizzle Biotechnology Holdings Plc
1.4780
-4.65%
SBTX.L SkinBioTherapeutics plc
21.20
-3.64%
IMM.L ImmuPharma plc
3.0001
-4.30%
OXB.L Oxford Biomedica plc
286.50
-4.50%
AVCT.L Avacta Group Plc
33.30
-2.06%
XNCR Xencor, Inc.
8.46
-21.08%
HOOK HOOKIPA Pharma Inc.
1.4800
+15.63%
ASND Ascendis Pharma A/S
162.84
-4.63%